SXTPNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SXTPW
60 DEGREES PHARMACEUTICALS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.83−0.03 (-3.29%)
Close on Oct 19, 2026
- Market cap
- $2.20M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$5.1327 (−86.12%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
60 DEGREES PHARMACEUTICALS, INC. grew revenue 73.2% to $1.11M over the twelve months to Jun 30, 2026. Free cash flow was -$8.89M.
Revenue
$1.11M
+73.2% vs. a year earlier
Operating income
-$8.61M
TTM Q2 2026
Free cash flow
-$8.89M
TTM Q2 2026
EPS, diluted
-$11.73
FY2025
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $2.20M
- P/E ratio
- –
- Price to sales
- 1.98
- Price to book
- 0.84
- Dividend yield
- –
- Free cash flow yield
- -405.13%
Fundamentals
- Revenue
- $1.11M
- Net income
- -$8.11M
- EPS, diluted
- -$11.73
- Free cash flow
- -$8.89M
- Book value per share
- $0.99
- Diluted shares
- 3M
Five years at a glance
Fiscal years 2021 to 2025 and trailing twelve months, USD
Revenue
$1.11M+73.2% YoY
Gross profit
$215.79K-25.2% YoY
Operating income
-$8.61M
Net income
-$8.11M
EPS, diluted
–
Free cash flow
-$8.89M
Reported periodTrailing twelve months